Neuromodulation

Questions discussed in this category

What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?

1 Answer available

How have you gone about implementing TMS in your practice or institution?

Logistical barriers in implementing TMS can include equipment acquisition, funding, staffing, training, reimbursement, or institutional approval. What...

3 Answers available

When do you consider referring adolescents with major depressive disorder for TMS?

How effective have you found it in this population? Have you encountered any challenges with insurance coverage? How have you identified providers in ...

1 Answer available

How do you facilitate access to interventional treatments such as TMS for patients with difficult-to-treat depression who are on Medicaid?

1 Answer available

When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?

2 Answers available

At what point do you consider referring for neuromodulatory treatments (TMS, deep brain stimulation) for treatment refractory-OCD?

4 Answers available

How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?

1 Answer available

How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?

1 Answer available

Papers discussed in this category

Biological psychiatry, 2010-01-15

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Molecular psychiatry, 2018-10-03

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Journal of affective disorders, 2020 Jul 21

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.

The Journal of clinical psychiatry, 2023 Feb 01

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

CNS drugs, 2023 Aug 09

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023 May 12

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

Biological psychiatry. Cognitive neuroscience and neuroimaging, 2023 Jun 19

A Meta-analysis of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder.

Brain stimulation, 2023 Feb 19

Accelerated deep transcranial magnetic stimulation using iTBS protocol for refractory obsessive-compulsive disorder.

Cureus, 2024 May 23

The Clinical Efficacy of Accelerated Deep Repetitive Transcranial Magnetic Stimulation in Depression and Obsessive-Compulsive Disorder: Multi-centric Real-World Observational Data.

Biological psychiatry, 2019 Aug 09

Antidepressant Efficacy of Prolonged Intermittent Theta Burst Stimulation Monotherapy for Recurrent Depression and Comparison of Methods for Coil Positioning: A Randomized, Double-Blind, Sham-Controlled Study.

Related Topics